Ontology highlight
ABSTRACT:
SUBMITTER: Kelley BG
PROVIDER: S-EPMC3163760 | biostudies-other | 2011 Oct
REPOSITORIES: biostudies-other
Kelley Brooke G BG Mermelstein Paul G PG
Molecular and cellular neurosciences 20110719 2
The administration of progesterone as a neuroprotective agent following traumatic brain injury has recently entered phase III clinical trials. Previous work has demonstrated that therapeutic concentrations of progesterone decrease excitotoxicity through direct inhibition of voltage-gated calcium channels, an action independent of the nuclear progesterone receptor. Here we report using cultured rat striatal neurons that these same concentrations of progesterone also block voltage-gated potassium ...[more]